Pancreatic Surgery Clinical Trial
Official title:
Prevention of Postoperative Pancreatic Fistula by SOMATOSTATIN Compared to OCTREOTIDE: Prospective, Randomized, Controlled Study
The purpose of this study is to determine whether somatostatin is more effective that octreotide in the prevention of post-pancreatectomy pancreatic fistula
Prevention of pancreatic fistula remains a major challenge for surgeons, and various technical and pharmacological intervention have been investigated, with conflicting results. Despite several prospective studies, and metaanalyses, the prophylactic role on pancreatic fistula of octreotide, remains controversial, even if recommended for routine use in patients undergoing pancreatic resection. In view of recent result, the investigators can hypothesize that higher affinity for somatostatin-receptor lead to stronger pancreatic exocrine secretion inhibition, and better pancreatic fistula prevention. Consequently, continuous intravenous infusion of somatostatin-14, the natural peptide hormone, associated with 10 to 50 time stronger affinity with all somatostatin receptor, will be associated with a improved pancreatic fistula prevention compared to octreotide. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03462602 -
Nasogastric Tube in Pancreatic Surgery
|
N/A | |
Recruiting |
NCT05603702 -
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
|
Phase 1 | |
Completed |
NCT04196816 -
Surgery for Pancreatic Cancer With Oligo-Metastasis
|
||
Completed |
NCT03791346 -
Pancreatectomy for NET: External Evaluation of WHO 2017 Grading System
|
||
Recruiting |
NCT06381362 -
Italian Registry of Minimally Invasive Pancreatic Surgery
|
||
Completed |
NCT01059097 -
Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy
|
N/A | |
Withdrawn |
NCT00671463 -
Pancreatic Stent to Prevent Leak After Distal Pancreatectomy
|
N/A |